287 related articles for article (PubMed ID: 32984010)
1. Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer.
Wang S; Yang J; Ding C; Li J; You L; Dai M; Zhao Y
Front Oncol; 2020; 10():1539. PubMed ID: 32984010
[No Abstract] [Full Text] [Related]
2. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.
Li G; Cai Y; Wang C; Huang M; Chen J
J Neurooncol; 2019 Jul; 143(3):525-536. PubMed ID: 31172354
[TBL] [Abstract][Full Text] [Related]
4. Transducin-Like Enhancer of Split-1 Inhibits Malignant Behaviors
Wang Y; Yuan D; Zhou L; Liang Z; Zhou W; Lu J; Jiang B; You L; Guo J; Zhao YP
Front Oncol; 2020; 10():576. PubMed ID: 32432037
[No Abstract] [Full Text] [Related]
5. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
6. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
[TBL] [Abstract][Full Text] [Related]
8. SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway.
Gong S; Xiong L; Luo Z; Yin Q; Huang M; Zhou Y; Li J
Exp Ther Med; 2022 Aug; 24(2):502. PubMed ID: 35837046
[TBL] [Abstract][Full Text] [Related]
9. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
Front Oncol; 2020; 10():49. PubMed ID: 32117719
[No Abstract] [Full Text] [Related]
10. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
[TBL] [Abstract][Full Text] [Related]
11. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
Xu Y; Yao Y; Gao P; Cui Y
Biochem Biophys Res Commun; 2019 Jan; 509(1):138-142. PubMed ID: 30591218
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma.
Zhang Y; Zhang R; Luo G; Ai K
J Cancer; 2018; 9(15):2713-2722. PubMed ID: 30087712
[TBL] [Abstract][Full Text] [Related]
13. Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling.
Xu D; Yuan H; Meng Z; Yang C; Li Z; Li M; Zhang Z; Gan Y; Tu H
J Cancer; 2020; 11(8):2101-2112. PubMed ID: 32127937
[TBL] [Abstract][Full Text] [Related]
14. Distinctive structure of the human GSTM3 gene-inverted orientation relative to the mu class glutathione transferase gene cluster.
Patskovsky YV; Huang MQ; Takayama T; Listowsky I; Pearson WR
Arch Biochem Biophys; 1999 Jan; 361(1):85-93. PubMed ID: 9882431
[TBL] [Abstract][Full Text] [Related]
15. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract][Full Text] [Related]
16. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
17. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
19. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
20. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]